- Home
- SELF vs TARA Comparison
SELF vs TARA Comparison
Compare SELF & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- TARA
- Stock Information
- Founded
- SELF 1983
- TARA N/A
- Country
- SELF United States
- TARA United States
- Employees
- SELF N/A
- TARA N/A
- Industry
- SELF Real Estate Investment Trusts
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SELF Real Estate
- TARA Health Care
- Exchange
- SELF Nasdaq
- TARA Nasdaq
- Market Cap
- SELF 57.5M
- TARA 52.4M
- IPO Year
- SELF N/A
- TARA N/A
- Fundamental
- Price
- SELF $5.13
- TARA $2.47
- Analyst Decision
- SELF
- TARA Strong Buy
- Analyst Count
- SELF 0
- TARA 2
- Target Price
- SELF N/A
- TARA $24.00
- AVG Volume (30 Days)
- SELF 13.1K
- TARA 235.4K
- Earning Date
- SELF 11-08-2024
- TARA 11-12-2024
- Dividend Yield
- SELF 5.68%
- TARA N/A
- EPS Growth
- SELF 39.82
- TARA N/A
- EPS
- SELF 0.28
- TARA N/A
- Revenue
- SELF $12,319,724.00
- TARA N/A
- Revenue This Year
- SELF N/A
- TARA N/A
- Revenue Next Year
- SELF N/A
- TARA N/A
- P/E Ratio
- SELF $18.36
- TARA N/A
- Revenue Growth
- SELF 0.38
- TARA N/A
- 52 Week Low
- SELF $4.01
- TARA $1.04
- 52 Week High
- SELF $5.85
- TARA $5.24
- Technical
- Relative Strength Index (RSI)
- SELF 53.20
- TARA 57.56
- Support Level
- SELF $5.10
- TARA $2.43
- Resistance Level
- SELF $5.29
- TARA $2.74
- Average True Range (ATR)
- SELF 0.15
- TARA 0.19
- MACD
- SELF 0.02
- TARA -0.00
- Stochastic Oscillator
- SELF 57.89
- TARA 45.23
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).